These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10578353)

  • 41. Introduction: Focus on hematology. CD34(+) or CD34(-): does it really matter?
    Goodell MA
    Blood; 1999 Oct; 94(8):2545-7. PubMed ID: 10515855
    [No Abstract]   [Full Text] [Related]  

  • 42. Stem cell selection for autologous bone marrow transplantation.
    Okarma TB
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):9-20. PubMed ID: 1377406
    [No Abstract]   [Full Text] [Related]  

  • 43. In search of the self-renewing hematopoietic stem cell.
    Williams DA
    Blood Cells; 1991; 17(2):296-300. PubMed ID: 1717082
    [No Abstract]   [Full Text] [Related]  

  • 44. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection.
    Cipolone KM; Carter CS; Yu M; Cottler-Fox M
    Prog Clin Biol Res; 1994; 389():667-73. PubMed ID: 7535463
    [No Abstract]   [Full Text] [Related]  

  • 45. Optimization of CD34+ cell selection using immunomagnetic beads: implications for use in cryopreserved peripheral blood stem cell collections.
    Farley TJ; Ahmed T; Fitzgerald M; Preti RA
    J Hematother; 1997 Feb; 6(1):53-60. PubMed ID: 9112218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The diversity of human hematopoietic stem/progenitor cells. I. Two-color flow cytometric analysis of the different functional subpopulations of CD 34+ hematopoietic stem/progenitor cells riched from human bone marrow].
    Xi YZ; Zhang SX; Tang PH; Wei W; Kong FH
    Shi Yan Sheng Wu Xue Bao; 1996 Mar; 29(1):49-57. PubMed ID: 9208642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction.
    Croockewit A; Raymakers RA; Trilsbeek C; Dolstra H; Pennings A; De Witte TJ; Haanen C
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():83-8. PubMed ID: 7516921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotype and progeny of primitive adherent human hematopoietic progenitors.
    Gordon MY; Lewis JL; Grand FH; Marley SB; Goldman JM
    Leukemia; 1996 Aug; 10(8):1347-53. PubMed ID: 8709641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enrichment of hematopoietic stem cells from human vertebral body marrow.
    Kenyon NS; Russell TR; Xu XM; Knapp J; Ricordi C
    Transplant Proc; 1997 Jun; 29(4):1951. PubMed ID: 9193467
    [No Abstract]   [Full Text] [Related]  

  • 50. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
    Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
    J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lineage commitment of CD34+ human hematopoietic progenitor cells.
    Tjønnfjord GE; Steen R; Veiby OP; Egeland T
    Exp Hematol; 1996 Jul; 24(8):875-82. PubMed ID: 8690045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation.
    Reisner Y; Bachar-Lustig E; Li HW; Aversa F; Velardi A; Martelli MF
    Ann N Y Acad Sci; 1999 Apr; 872():336-48; discussion 348-50. PubMed ID: 10372136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Flow cytometry identification of CD34-positive cells].
    Tichelli A; Kralj A; Huxol H; Schönenberger A; Rabaglio M; Borel J; Müller R; Bargetzi M; Gratwohl A; Signer E
    Schweiz Med Wochenschr; 1995 Mar; 125(9):400-4. PubMed ID: 7534431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality control for peripheral stem cell collection: the Ottawa experience.
    Giulivi A; Huebsch LB; Van der Jagt R; Markman S; Fuller V; Birch P; Demone J; McDiermid S; Rutherford B
    Prog Clin Biol Res; 1994; 389():753-9. PubMed ID: 7535465
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of retroviral gene transfer into highly purified human CD34(-) cells with primitive hematopoietic capacity.
    Murdoch B; Gallacher L; Chadwick K; Bhatia M
    Mol Ther; 2002 May; 5(5 Pt 1):635-43. PubMed ID: 11991755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the CD34 enumeration on the day before stem cell harvest that best predicts poor mobilization.
    Szwajcer D; Jennings-Coutts A; Giftakis A; Wall DA
    Transfusion; 2011 Mar; 51(3):587-90. PubMed ID: 21388392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transplantation of stem cells enriched by immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz DF; Heimfeld S; Goffe RA; Berninger RW; Peterson DR; Thompson P; Strong DM
    Prog Clin Biol Res; 1992; 377():449-57; discussion 458-9. PubMed ID: 1279714
    [No Abstract]   [Full Text] [Related]  

  • 58. Analysis of candidate human blood stem cells in "humanized" immune-deficiency SCID mice.
    Péault B; Weissman I; Baum C
    Leukemia; 1993 Aug; 7 Suppl 2():S98-101. PubMed ID: 7689676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD34 positive cell selection by immunomagnetic techniques.
    Bigas A; Amill B; Canals C; Tugues D; García J
    Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
    [No Abstract]   [Full Text] [Related]  

  • 60. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
    Tian H; Huang S; Gong F; Tian L; Chen Z
    Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.